west
nile
viru
wnv
respons
largest
outbreak
arbovir
enceph
us
histori
specif
drug
current
avail
effect
treatment
wnv
infect
exploit
rna
interfer
potenti
therapeut
approach
moloney
murin
leukemia
virusbas
retroviru
vector
use
effect
deliv
wnvspecif
small
interf
rna
sirna
human
neuroblastoma
cell
viral
plaqu
assay
demonstr
transduc
cell
significantli
refractori
wnv
replic
compar
untransduc
control
cell
p
correl
reduc
express
target
viral
gene
respect
viral
protein
therefor
retrovirusmedi
deliveri
sirna
gene
silenc
use
studi
specif
function
viral
gene
associ
replic
may
potenti
therapeut
applic
like
mosquitoborn
human
pathogen
virus
yellow
fever
viru
dengu
virus
west
nile
viru
wnv
envelop
rna
viru
belong
genu
flaviviru
famili
flavivirida
wnv
contain
singl
plussens
rna
genom
approxim
kb
encod
singl
long
open
read
frame
encod
polyprotein
coand
posttransl
process
viral
cellular
proteas
three
structur
protein
capsid
c
premembran
prm
membran
envelop
e
protein
seven
nonstructur
protein
rice
sampson
et
al
brinton
wnv
recent
recogn
major
human
pathogen
follow
outbreak
human
enceph
report
romania
russia
israel
particular
new
york
citi
anderson
et
al
lanciotti
roehrig
savag
et
al
lvov
et
al
hindiyeh
et
al
mazurek
et
al
subsequ
wnv
spread
throughout
continent
unit
state
spare
alaska
hawai
us
epidem
largest
wnv
outbreak
ever
report
case
infect
includ
case
mening
enceph
report
center
diseas
control
prevent
cdc
case
neuroinvas
wnv
infect
includ
fatal
report
current
effect
drug
vaccin
avail
treat
prevent
wnv
infect
human
phenomenon
rna
interfer
rnai
cellular
process
degrad
specif
rna
within
cytoplasm
cell
sequencespecif
manner
elbashir
et
al
agami
paddison
et
al
rnai
occur
natur
plant
nematod
parasit
insect
mammalian
cell
believ
function
regul
cellular
gene
express
possibl
innat
defens
viral
infect
jorgensen
romano
macino
fire
et
al
agami
gitlin
et
al
paddison
et
al
use
small
interf
rna
sirna
becom
power
tool
downregul
knock
express
specif
gene
mammalian
cell
well
whole
organ
elbashir
et
al
paddison
et
al
sui
et
al
furthermor
mani
mammalian
virus
appear
suscept
treatment
exogen
sirna
gitlin
et
al
lindenbach
rice
novina
et
al
hall
alexand
kapadia
et
al
mccaffrey
et
al
wilson
et
al
wiebusch
et
al
zhang
et
al
ong
et
al
weinberg
et
al
sequencespecif
activ
sirna
virus
lead
great
deal
interest
potenti
use
new
approach
toward
antivir
therapi
carmichael
cullen
lindenbach
rice
shuey
et
al
silva
et
al
plasmidand
oligonucleotidebas
system
possess
potenti
widespread
use
howev
limit
instabl
inabl
longterm
use
well
depend
transfect
certain
cell
line
transfect
effici
contrast
retrovir
gene
deliveri
effect
cell
line
includ
mani
primari
cell
type
fertil
egg
use
gener
transgen
anim
barquinero
et
al
experiment
data
demonstr
effici
inhibit
wnv
replic
achiev
human
neuroblastoma
cell
line
use
moloney
murin
leukemia
viru
mmlv
base
retrovir
deliveri
system
wnvspecif
sirna
human
pol
iii
promot
amplifi
human
genom
dna
pair
primer
bam
hi
site
introduc
end
allow
insert
sirna
sequenc
posit
transcript
pcr
fragment
clone
bgl
ii
mlu
site
mmlv
retrovir
vector
plasmid
bp
newli
modifi
vector
laboratori
replac
neo
egfp
insert
ori
downstream
enhanc
viral
vector
replic
cell
express
larg
antigen
five
specif
sequenc
sirna
base
genom
wnv
flamingo
select
use
onlin
program
sirna
target
finder
ambion
austin
tx
sirna
target
differ
region
structur
nonstructur
gene
nt
nt
nt
nt
nt
fig
one
sequenc
contain
mismatch
nucleotid
underlin
origin
target
site
nt
select
neg
control
sequenc
analyz
use
blast
search
program
genbank
databas
avoid
analog
sequenc
found
human
genom
oligonucleotid
sequenc
along
complementari
strand
synthes
anneal
subclon
mmlv
retroviralvector
backbon
mlu
bam
hi
site
control
human
promot
human
embryon
kidney
cell
line
obtain
atcc
maintain
dmem
fetal
bovin
serum
fb
hyclon
logan
ut
use
vector
product
human
tcell
cem
grown
medium
supplement
fb
antibiot
employ
vector
titrat
african
green
monkey
kidney
vero
cell
employ
wnv
titrat
human
neuroblastoma
cell
line
maintain
mem
fb
penicillin
u
streptomycin
wnv
strain
flamingo
propag
plaqu
titrat
vero
cell
cell
exponenti
growth
phase
cm
flask
transfect
calcium
phosphat
precipit
pvsvg
clontech
mountain
view
ca
packag
plasmid
pampho
provid
dr
v
planel
univers
utah
salt
lake
citi
cell
medium
replac
hr
posttransfect
posttransfect
cell
medium
collect
transfect
cell
filter
filter
spun
g
hr
pellet
vectorviru
resuspend
small
volum
origin
volum
medium
aliquot
mlvial
store
futur
use
vectorviru
titrat
cem
cell
use
serial
dilut
vector
titer
determin
day
postinfect
evalu
gfp
express
infect
cem
cell
cultur
gener
transduc
cell
approxim
htb
cell
exponenti
growth
phase
trypsin
count
infect
concentr
retroviralvector
stock
presenc
polybren
follow
incub
transduc
cell
transfer
cm
flask
cultur
fresh
medium
ascertain
transduct
effici
basi
gfp
express
gfpexpress
cell
select
clone
two
three
cycl
limitingdilut
cell
clone
method
viru
infect
sampl
supernat
measur
titrat
plaqu
assay
briefli
mlwell
serial
dilut
sampl
inocul
onto
vero
cell
monolay
grown
sixwel
cell
cultur
plate
incub
hr
co
unabsorb
residu
viru
remov
ml
overlay
medium
contain
agar
mg
l
sodium
bicarbon
mgl
lglutamin
antibiot
ad
well
addit
incub
hr
mlwell
second
overlay
contain
agar
neutral
red
dye
ad
infect
cultur
plaqu
visual
plaqu
score
day
postinocul
hr
postinfect
total
rna
extract
wnvinfect
cell
use
rneasi
mini
kit
qiagen
valencia
ca
accord
manufactur
recommend
revers
transcript
reaction
carri
use
superscript
ii
revers
transcriptas
gibson
grand
island
ny
accord
manufactur
instruct
reaction
mixtur
contain
mg
total
rna
final
volum
brought
h
use
realtim
pcr
analysi
cdna
amplifi
reaction
volum
nm
concentr
primer
use
iq
sybr
green
super
mix
biorad
hercul
ca
primer
use
studi
describ
previous
papin
et
al
target
specif
env
region
wnv
human
dehydrogen
gapdh
primer
use
intern
control
assay
reaction
perform
realtim
pcr
detect
system
biorad
follow
denatur
step
min
cycl
amplif
perform
sec
min
sampl
run
triplic
data
analyz
accord
compar
threshold
cycl
ct
method
amount
target
wnvenv
normal
endogen
refer
gapdh
rel
experiment
control
viru
given
ct
indic
pcr
cycl
number
amount
amplifi
target
reach
fix
threshold
valu
determin
subtract
averag
refer
ct
valu
averag
target
ct
valu
valu
involv
subtract
experiment
control
valu
livak
schmittgen
hr
postinfect
cell
harvest
total
cellular
protein
extract
protein
concentr
determin
use
biorad
protein
assay
kit
biorad
extract
cellular
protein
subject
sdspage
separ
protein
transfer
pvdfplu
membran
osmon
westborough
use
xcell
ii
system
invitrogen
carlsbad
ca
recov
membran
blot
primari
antibodi
monoclon
antiwnv
envelop
antibodi
dilut
follow
incub
antimous
secondari
antibodi
conjug
horseradish
peroxidas
kpl
gaithersburg
md
viral
protein
detect
use
super
signal
west
pico
chemiluminesc
pierc
rockford
il
human
gapdh
use
load
control
detect
monoclon
antigapdh
antibodi
visual
band
measur
use
chemidoc
xr
system
biorad
oneway
anova
follow
bonferroni
multipl
comparison
test
softwar
prism
ttest
employ
statist
analysi
studi
differ
two
sampl
consid
signific
pvalu
less
human
neuroblastoma
cell
use
wnv
neurotrop
viru
infect
htb
cell
induc
cytopath
effect
cpe
studi
specif
inhibitori
effect
retrovir
vectormedi
sirna
express
wnv
replic
htb
cell
five
sirnaexpress
retrovir
vector
target
wnv
genom
gener
htb
cell
stabli
express
sirna
select
limit
dilut
method
cell
infect
retrovir
vector
wnv
multipl
infect
moi
cell
cultur
supernat
collect
hr
postinfect
product
infecti
wnv
transduc
normal
control
htb
cell
compar
measur
use
viral
plaqu
assay
shown
figur
viru
product
cell
express
sirna
vari
compar
level
viru
propag
control
cell
depend
sirna
express
transduc
cell
exhibit
vari
inhibitori
impact
wnv
replic
effici
viral
inhibit
occur
use
sirna
target
site
wnv
cap
gene
fig
addit
notabl
mismatch
control
sirna
show
inhibitori
effect
viru
product
amount
wnv
viral
rna
transcript
sirnaexpress
cell
quantifi
realtim
pcr
htb
cell
infect
sirnaexpress
retroviru
cell
subject
wnv
infect
moi
infect
cell
harvest
hr
postinfect
subject
realtim
pcr
cell
express
sirna
show
reduct
viral
transcript
compar
detect
wnvinfect
control
cell
fig
therefor
wnv
specif
sirna
capabl
reduc
amount
viral
rna
transcript
confirm
inhibitori
effect
retrovir
vectormedi
sirna
express
wnv
replic
express
level
viral
protein
transduc
cell
assess
express
level
major
viral
structur
envelop
e
glycoprotein
repres
degrad
entir
viral
genom
determin
western
blot
assay
indic
figur
decreas
amount
viral
envelop
protein
detect
hr
postinfect
cell
express
sirna
target
cap
gene
compar
wildtyp
wnvinfect
cell
transduc
mismatch
sirna
untransduc
control
cell
similarli
concentr
viral
e
protein
also
significantli
lower
sirna
retrovirusinfect
cell
hr
postinfect
compar
wnvinfect
control
cell
p
although
increas
quantiti
viral
protein
hr
postinfect
sirna
retrovirusinfect
cell
still
show
lower
amount
viral
e
protein
mockinfect
htb
cell
act
neg
control
yield
band
two
time
point
fig
indic
antisera
abl
react
specif
target
viral
protein
success
rnai
produc
inhibit
viral
replic
cycl
alreadi
demonstr
varieti
anim
virus
novina
et
al
banerjea
et
al
hepat
c
viru
kapadia
et
al
wilson
et
al
hepat
b
viru
mccaffrey
et
al
weinberg
et
al
sarscov
viru
zhang
et
al
human
papillomaviru
viru
hall
alexand
cytomegaloviru
wiebusch
et
al
high
specif
versatil
effici
sirnamedi
inhibit
viral
replic
suggest
potenti
use
therapi
prophylaxi
viral
diseas
carmichael
cullen
gitlin
et
al
lindenbach
rice
thu
necessari
abl
effici
deliv
express
sirna
target
cell
effect
inhibit
viru
infect
studi
demonstr
first
use
retrovir
vectordeliv
rnai
wnv
viru
cultur
human
neuroblastoma
cell
standard
molecular
clone
techniqu
employ
construct
gener
five
differ
sirna
retrovirus
correspond
differ
region
wnv
genom
capsid
membran
envelop
capsid
membran
envelop
structur
protein
nonstructur
protein
rna
depend
rnapolymeras
rdrp
shown
result
sirna
target
wnv
effici
deliv
retrovir
vector
express
control
pol
iii
promot
human
neuroblastoma
cell
wnv
product
cultur
fluid
infect
cell
well
level
wnv
envelop
protein
decreas
retrovir
vectormedi
deliveri
wnv
specif
sirna
among
sirna
test
wnvspecif
sirna
target
viral
nucleocapsid
protein
highli
effect
result
reduct
viru
product
wherea
wnv
sirna
provid
partial
inhibit
wnv
replic
find
consist
recent
report
vari
impact
sirna
wnv
replic
rang
inhibitori
effect
almost
complet
viral
inhibit
mccowna
et
al
bai
et
al
geiss
et
al
kumar
et
al
ong
et
al
ong
et
al
report
appar
inhibit
wnv
replic
plasmid
vector
express
sirna
target
gene
wnv
wnv
envelop
gene
also
success
test
target
gene
recent
studi
kumar
et
al
bai
et
al
sever
site
anoth
research
group
test
multipl
site
wnv
genom
demonstr
limit
inhibitori
effect
geiss
et
al
variat
sirnamedi
antivir
effect
attribut
sever
factor
includ
level
sirna
express
transduc
cell
inher
inabl
individu
sirna
molecul
target
gene
within
viral
genom
sinc
retrovir
vector
known
mediat
high
level
express
trangen
sulleng
et
al
lu
et
al
habu
et
al
select
sirna
molecul
may
larg
respons
moder
level
antiwnv
replic
detect
studi
addit
differ
deliveri
system
host
cell
use
report
experiment
result
also
point
toward
import
specif
sequenc
within
wnv
genom
target
sirna
data
indic
great
variat
sequencespecif
rnai
therefor
empir
verif
effect
design
sequenc
suppress
target
gene
requir
poor
inhibit
target
site
probabl
due
rna
bind
complex
regulatori
protein
involv
replic
translat
structur
stabil
chen
et
al
brinton
banerjea
et
al
moreov
sequenc
viral
mrna
might
buri
within
secondari
structur
highli
fold
region
may
easili
access
interact
sirna
bohula
et
al
kretschmerkazemi
et
al
luo
chang
reynold
et
al
factor
partli
explain
variat
viru
suppress
observ
studi
addit
level
product
stabil
sirna
may
also
affect
interf
abil
hohjoh
recent
report
demonstr
success
wnv
inhibit
sirna
use
lentiviru
vector
kumar
et
al
fact
sirna
success
deliv
express
viral
vector
retrovirus
barton
medzhitov
devro
silver
lentivirus
abbasterki
et
al
et
al
banerjea
et
al
adenovirus
shen
et
al
shen
resk
suppress
specif
protein
synthesi
interfer
viru
replic
howev
retrovir
sirna
system
wide
use
gene
therapi
tool
reportedli
use
suppress
wnv
infect
result
studi
demonstr
wnvspecif
sirna
deliv
express
effect
retrovir
vector
system
use
suppress
wnv
viru
protein
express
replic
level
inhibit
viral
protein
express
replic
observ
studi
moder
similar
report
studi
use
plasmid
vector
sirna
nucleotid
lentiviru
vector
mccowna
et
al
bai
et
al
geiss
et
al
kumar
et
al
ong
et
al
conclus
studi
demonstr
retrovirusmedi
sequencespecif
wnv
sirna
express
could
use
interfer
viral
protein
synthesi
inhibit
viru
replic
thu
suggest
potenti
applic
therapi
wnv
infect
result
studi
suggest
retroviralvector
express
sirna
could
use
tool
address
complex
interact
viral
cellular
regulatori
protein
involv
viru
life
cycl
current
result
argu
studi
focus
test
sirna
sequenc
target
viral
gene
order
achiev
improv
inhibitori
impact
wnv
infect
schemat
represent
select
target
site
five
sirna
sequenc
wnv
rna
genom
b
complet
human
polymeras
iii
transcript
unit
insert
murin
leukemia
viru
mmlv
retrovir
vector
use
uniqu
bgl
ii
mlu
restrict
endonucleas
site
revers
transcript
portion
serv
templat
gener
new
black
portion
region
schemat
repres
unit
express
sirna
copi
ltr
retroviru
packag
signal
human
promot
ter
transcript
termin
wnv
replic
sirna
express
htb
cell
variou
sirnaexpress
htb
cell
untransduc
control
cell
seed
cell
tissu
cultur
cm
flask
infect
wild
type
wnv
moi
viru
replic
postinfect
compar
use
plaqu
assay
mock
htb
cell
without
wnv
infect
mismatch
mutat
sirna
wnv
sirna
wnv
control
wnvinfect
sirna
naiv
htb
cell
data
present
mean
sd
n
attenu
wnv
mrna
transcript
sirna
htb
cell
transduc
variou
retrovir
vector
express
sirna
target
wnv
genom
infect
wnv
moi
cell
harvest
hr
pi
mrna
extract
revers
transcrib
cdna
cdna
subject
realtim
pcr
analysi
use
genespecif
primer
wnv
gapdh
chang
nfold
wnv
mrna
level
present
normal
gapdh
endogen
refer
rel
viru
sampl
experiment
control
control
wnvinfect
sirna
naiv
htb
cell
mismatch
mutat
sirna
wnv
sirna
envelop
capsid
wnv
data
present
mean
standard
deviat
deriv
three
independ
experi
sirnamedi
reduct
wnv
protein
express
wnvinfect
htb
cell
htb
cell
transduc
variou
retrovir
vector
express
sirna
target
wnv
genom
infect
wnv
multipl
infect
total
cellular
protein
harvest
hr
postinfect
western
blot
analysi
perform
use
antibodi
wnv
envelop
protein
antigapdh
antibodi
intern
control
mock
neg
control
htb
cell
without
wnv
infect
mismatch
mutat
sirna
wnv
sirna
wnv
c
posit
control
wnvinfect
sirna
naiv
htb
cell
repres
western
blot
depict
result
obtain
three
independ
experiment
test
